362 related articles for article (PubMed ID: 34921391)
1. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
[TBL] [Abstract][Full Text] [Related]
2. The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.
Lloyd A; McIntosh E; Price M
Pharmacoeconomics; 2005; 23(11):1167-81. PubMed ID: 16277551
[TBL] [Abstract][Full Text] [Related]
3. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
Mühlbacher AC; Nübling M
Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
[TBL] [Abstract][Full Text] [Related]
4. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
[TBL] [Abstract][Full Text] [Related]
5. Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.
Collacott H; Phillips-Beyer A; Krucien N; Flamion B; Marsh K
Patient; 2024 May; 17(3):287-300. PubMed ID: 38270788
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
7. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
González JM; Doan J; Gebben DJ; Boeri M; Fishman M
Pharmacoeconomics; 2018 Aug; 36(8):973-986. PubMed ID: 29869777
[TBL] [Abstract][Full Text] [Related]
9. Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies.
Ettinger AB; Carter JA; Rajagopalan K
Epilepsy Behav; 2018 Mar; 80():247-253. PubMed ID: 29433949
[TBL] [Abstract][Full Text] [Related]
10. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
[TBL] [Abstract][Full Text] [Related]
11. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
[TBL] [Abstract][Full Text] [Related]
12. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.
Stone RL; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Ritz S; Mulvihill E; Monberg M; Szamreta EA; Amin S; McLaurin K
Future Oncol; 2022 Feb; 18(4):491-503. PubMed ID: 34875854
[TBL] [Abstract][Full Text] [Related]
13. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Bruni C; Heidenreich S; Duenas A; Hoffmann-Vold AM; Gabrielli A; Allanore Y; Chatelus E; Distler JHW; Hachulla E; Hsu VM; Hunzelmann N; Khanna D; Truchetet ME; Walker UA; Alves M; Schoof N; Saketkoo LA; Distler O
Rheumatology (Oxford); 2022 Oct; 61(10):4035-4046. PubMed ID: 35238334
[TBL] [Abstract][Full Text] [Related]
15. Patients' and professionals' preferences in terms of the attributes of home enteral nutrition products in Spain. A discrete choice experiment.
Olveira G; Ángel Martínez-Olmos M; de Bobadilla BF; Ferrer M; Virgili N; Vega B; Blanco M; Layola M; Lizán L; Gozalbo I
Eur J Clin Nutr; 2018 Feb; 72(2):272-280. PubMed ID: 29259337
[TBL] [Abstract][Full Text] [Related]
16. Patients' preferences for primary health care - a systematic literature review of discrete choice experiments.
Kleij KS; Tangermann U; Amelung VE; Krauth C
BMC Health Serv Res; 2017 Jul; 17(1):476. PubMed ID: 28697796
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.
Feldman SR; Guerin A; Gauthier-Loiselle M; Claxton AJ; Hazra NC; Meng Y; Gallant K; Balu S
J Dermatolog Treat; 2024 Dec; 35(1):2345739. PubMed ID: 38705585
[No Abstract] [Full Text] [Related]
18. Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders-Patients, Primary Care Physicians, and Policy Makers.
Chudner I; Drach-Zahavy A; Karkabi K
Value Health; 2019 Oct; 22(10):1187-1196. PubMed ID: 31563262
[TBL] [Abstract][Full Text] [Related]
19. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
Patient; 2012; 5(1):33-44. PubMed ID: 22077619
[TBL] [Abstract][Full Text] [Related]
20. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]